Journal Watch · Bioengineering & Translational Medicine · 2026

ROS-responsive robust hydrogels based on thiol-ene click chemistry for enhancing the healing of infected wounds.

The THMA/TCMC-Gel@Cur hydrogel exhibited significant potential for clinical application, poised to enhance the quality of life for patients suffering from infectious dermatological disorders.

Li H, Zhong J, Bi C et al.Bioengineering & Translational Medicine3 min readPharma relevance 65/100

DOI: 10.1002/btm2.70143PMID: 42394901Study type: clinical study

TL;DR

The THMA/TCMC-Gel@Cur hydrogel exhibited significant potential for clinical application, poised to enhance the quality of life for patients suffering from infectious dermatological disorders.

Key findings

  • In vivo results showed that wounds treated with THMA/TCMC-Gel@Cur hydrogel had a wound closure ratio of 93.56% within 14 days, which was significantly higher than the other treatment groups.
  • The THMA/TCMC-Gel@Cur hydrogel exhibited significant potential for clinical application, poised to enhance the quality of life for patients suffering from infectious dermatological disorders.

Numbers at a glance (from the abstract)

93.56%

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

Thiols and alkenes quickly formed thioether bonds through the "thiol-ene" click chemical reaction. The hydrophobic thioether bonds could be oxidized to hydrophilic sulfoxide bonds by ROS. THMA/TCMC-Gel@Cur hydrogel formed by "thiol-ene" click chemistry could respond to ROS and increase water molecules to enter the interior of the hydrogel by switching the hydrophilic to hydrophobic characteristics, thereby accelerating drug diffusion in the porous network.

Full abstract (original)

Background: The development of novel antimicrobial wound healing dressings has become an urgent challenge with the increasing prevalence of drug-resistant bacterial infections. Herein, a reactive oxygen species (ROS) responsive robust hydrogel (THMA/TCMC-Gel@Cur) based on "thiol-ene" click chemistry was developed for infected wounds. The addition of curcumin-loaded gelatin nanoparticles (Gel@Cur) imparted excellent antibacterial and antioxidant properties to the THMA/TCMC-Gel@Cur hydrogel.

What they did: Thiols and alkenes quickly formed thioether bonds through the "thiol-ene" click chemical reaction. The hydrophobic thioether bonds could be oxidized to hydrophilic sulfoxide bonds by ROS. THMA/TCMC-Gel@Cur hydrogel formed by "thiol-ene" click chemistry could respond to ROS and increase water molecules to enter the interior of the hydrogel by switching the hydrophilic to hydrophobic characteristics, thereby accelerating drug diffusion in the porous network.

Results & conclusions: In vivo results showed that wounds treated with THMA/TCMC-Gel@Cur hydrogel had a wound closure ratio of 93.56% within 14 days, which was significantly higher than the other treatment groups. The THMA/TCMC-Gel@Cur hydrogel exhibited significant potential for clinical application, poised to enhance the quality of life for patients suffering from infectious dermatological disorders.

Abstract © the authors / Bioengineering & Translational Medicine (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1002/btm2.70143 · PubMed 42394901.

Why it matters for pharma & biotech

  • Relevant to Biotechnology & Methods teams tracking Bioengineering & Translational Medicine for new targets, mechanisms and biomarkers.
  • Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.

Frequently asked questions

What did this Bioengineering & Translational Medicine study find?

The THMA/TCMC-Gel@Cur hydrogel exhibited significant potential for clinical application, poised to enhance the quality of life for patients suffering from infectious dermatological disorders.

What type of study is this?

It is a clinical study, published in Bioengineering & Translational Medicine in 2026. Thiols and alkenes quickly formed thioether bonds through the "thiol-ene" click chemical reaction.

Where can I read the original paper?

The original is at the publisher via DOI 10.1002/btm2.70143. PubMed ID: 42394901. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Li H, Zhong J, Bi C et al.. ROS-responsive robust hydrogels based on thiol-ene click chemistry for enhancing the healing of infected wounds.. Bioengineering & Translational Medicine (2026). DOI: 10.1002/btm2.70143.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/ros-responsive-robust-hydrogels-based-on-thiol-ene-click-chemistry-for-e-270143/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides